Surgical Science Sweden Leads The Pack Of 3 Growth Stocks With Significant Insider Ownership

Simply Wall St.
17 Feb

As global markets experience a mix of optimism and caution, with U.S. stock indexes nearing record highs and inflation data prompting discussions on interest rate policies, investors are keenly observing growth stocks that show resilience amid these fluctuations. In this environment, companies with high insider ownership often attract attention for their potential alignment of interests between management and shareholders, offering a compelling case for those seeking growth opportunities.

Top 10 Growth Companies With High Insider Ownership

Name Insider Ownership Earnings Growth
Lavvi Empreendimentos Imobiliários (BOVESPA:LAVV3) 17.3% 22.8%
Archean Chemical Industries (NSEI:ACI) 22.9% 50.1%
Clinuvel Pharmaceuticals (ASX:CUV) 10.4% 26.2%
Propel Holdings (TSX:PRL) 36.5% 38.7%
Pricol (NSEI:PRICOLLTD) 25.4% 25.2%
On Holding (NYSE:ONON) 19.1% 29.7%
Kingstone Companies (NasdaqCM:KINS) 20.8% 24.9%
HANA Micron (KOSDAQ:A067310) 18.3% 119.4%
Fulin Precision (SZSE:300432) 13.6% 71%
Findi (ASX:FND) 35.8% 111.4%

Click here to see the full list of 1462 stocks from our Fast Growing Companies With High Insider Ownership screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Surgical Science Sweden

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Surgical Science Sweden AB (publ) specializes in developing and marketing virtual reality simulators for evidence-based medical training globally, with a market cap of SEK9.67 billion.

Operations: The company generates revenue from Industry/OEM at SEK419.66 million and Educational Products at SEK440.17 million.

Insider Ownership: 26.6%

Revenue Growth Forecast: 17.2% p.a.

Surgical Science Sweden is experiencing significant growth, with earnings projected to increase by 32.7% annually, outpacing the Swedish market. The company recently expanded into the defense sector with a US$4.7 million order for its TraumaVR product and strengthened ties with Intuitive through integration into da Vinci 5 systems. Despite trading below estimated fair value, revenue growth remains robust at 17.2%, surpassing market averages, though insider trading activity has been minimal recently.

  • Click to explore a detailed breakdown of our findings in Surgical Science Sweden's earnings growth report.
  • The valuation report we've compiled suggests that Surgical Science Sweden's current price could be inflated.
OM:SUS Ownership Breakdown as at Feb 2025

Shenzhen Sunline Tech

Simply Wall St Growth Rating: ★★★★★☆

Overview: Shenzhen Sunline Tech Co., Ltd. provides banking software and technology services to global banking and finance customers, with a market cap of CN¥12.17 billion.

Operations: Shenzhen Sunline Tech Co., Ltd.'s revenue is primarily derived from its banking software and technology services offered to financial institutions globally.

Insider Ownership: 21.6%

Revenue Growth Forecast: 21.2% p.a.

Shenzhen Sunline Tech is poised for substantial growth, with earnings projected to increase by 62.9% annually, outstripping the Chinese market average. Revenue is also expected to rise at a robust rate of 21.2% per year. Despite recent share price volatility and no significant insider trading activity, the company's focus on repurchasing and canceling restricted stocks indicates strategic capital management efforts as discussed in their recent shareholders meeting agenda.

  • Navigate through the intricacies of Shenzhen Sunline Tech with our comprehensive analyst estimates report here.
  • In light of our recent valuation report, it seems possible that Shenzhen Sunline Tech is trading beyond its estimated value.
SZSE:300348 Ownership Breakdown as at Feb 2025

Shenzhen Yinghe Technology

Simply Wall St Growth Rating: ★★★★★☆

Overview: Shenzhen Yinghe Technology Co., Ltd focuses on the R&D, production, and sale of lithium-ion battery automation equipment in China with a market cap of CN¥13.08 billion.

Operations: Shenzhen Yinghe Technology Co., Ltd generates revenue primarily through its involvement in the research, development, and sale of automation equipment for lithium-ion batteries within China.

Insider Ownership: 19.3%

Revenue Growth Forecast: 20.1% p.a.

Shenzhen Yinghe Technology is projected to experience strong growth, with earnings anticipated to increase by 32.3% annually, surpassing the Chinese market average. Revenue growth is expected at 20.1% per year. The company trades at a significant discount to its fair value and has announced a share repurchase program worth CNY 200 million for equity incentives, reflecting strategic capital management despite a low dividend coverage by free cash flows and no recent insider trading activity.

  • Click here to discover the nuances of Shenzhen Yinghe Technology with our detailed analytical future growth report.
  • Our valuation report here indicates Shenzhen Yinghe Technology may be undervalued.
SZSE:300457 Earnings and Revenue Growth as at Feb 2025

Seize The Opportunity

  • Unlock more gems! Our Fast Growing Companies With High Insider Ownership screener has unearthed 1459 more companies for you to explore.Click here to unveil our expertly curated list of 1462 Fast Growing Companies With High Insider Ownership.
  • Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.
  • Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.

Searching for a Fresh Perspective?

  • Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
  • Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
  • Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include OM:SUS SZSE:300348 and SZSE:300457.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10